MSC secretome from amniotic fluid halts IL-1β and TNF-α inflammation via the ERK/MAPK pathway, promoting cartilage regeneration in OA in vitro
Issued Date
2024-01-01
Resource Type
eISSN
09737154
Scopus ID
2-s2.0-85196078751
Journal Title
Journal of Stem Cells and Regenerative Medicine
Volume
20
Issue
1
Start Page
P03
End Page
P13
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Stem Cells and Regenerative Medicine Vol.20 No.1 (2024) , P03-P13
Suggested Citation
Klaymook S., Tirawanchai N., Wichitwiengrat S., Chuaynarong P., Thongbopit S., Chareancholvanich K., Phermthai T. MSC secretome from amniotic fluid halts IL-1β and TNF-α inflammation via the ERK/MAPK pathway, promoting cartilage regeneration in OA in vitro. Journal of Stem Cells and Regenerative Medicine Vol.20 No.1 (2024) , P03-P13. P13. doi:10.46582/jsrm.2001002 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/101150
Title
MSC secretome from amniotic fluid halts IL-1β and TNF-α inflammation via the ERK/MAPK pathway, promoting cartilage regeneration in OA in vitro
Author's Affiliation
Corresponding Author(s)
Other Contributor(s)
Abstract
Osteoarthritis (OA) is a degenerative disease that causes chronic pain and disability worldwide. This disease is mainly caused by IL-1β and TNF-α, which lead to cartilage degradation and inhibit the repair capacity of damaged cartilage. Recent studies have shown that amniotic fluid mesenchymal stem cells (AF-MSCs) secrete proteins that can effectively help in the treatment of cartilage damaged by OA. However, the underlying mechanism is still unclear. Therefore, the aim of this study was to investigate the effects and mechanisms behind the healing properties of the AF-MSC secretome (AFS-se) under OA conditions. This study involved growing chondrocyte progenitor cells (CPCs) and traumatized cartilage tissues in the presence of the cytokines IL-1β and TNF-α, which mimic OA conditions. AFS-se was then added to the culture medium to determine its effect on the CPCs and cartilage. Cell migration, endogenous cell outgrowth, the expression of chondrogenic and anabolic genes, and the mechanism of proteins in the NF-κB and MAPK signaling pathways were examined in this study. AFS-se inhibited the inflammatory effects of IL-1β and TNF-α by significantly reducing ERK phosphorylation in the MAPK signaling pathway and decreasing downstream proinflammatory COX2 products. The impaired CPCs recovered their ability to migrate, and endogenous CPCs in injured osteoarthritic cartilage were able to regrow in response to inflammatory stimuli. Additionally, the expression of anabolic genes such as Col I, Col II, and IGF1 was restored in defective CPCs. In conclusion, this study demonstrated that AFS-se has therapeutic effects on OA by inhibiting the inflammatory functions of IL-1β and TNF-α through protein phosphorylation in the MAPK pathway while also promoting the regenerative and self-repair functions of CPCs in traumatized cartilage.